Delivery Order SPE2DE22D0008-SPE2D626F38ZB
Award Date 2/2/26
Potential Completion Date 2/5/26
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency's Medical Supply Chain division awarded a $12,080 delivery order to Alba Bioscience, Inc. for ALBACLONE Anti-E monoclonal antibodies under a firm fixed price contract. The award, issued on October 30, 2025, with an ultimate completion date of November 4, 2025, represents a competitive procurement with no set-aside designation. Alba Bioscience, a Chicago-based subsidiary of Quotient Biodiagnostics, Inc., specializes in providing in vitro diagnostic products and...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $1,194.00 delivery order to Alba Bioscience, Inc. for ALBACLONE Anti-D Blend, a monoclonal antibody reagent used in blood banking and immunohematology testing. The contract is structured as a firm fixed-price delivery order with a completion date of January 30, 2026, and was awarded on January 27, 2026. This award carries no set-aside designation, reflecting Alba Bioscience's competitive standing as a specialized supplier...
- Alba Bioscience, Inc., a Chicago-based diagnostic supplier specializing in immunohematology reagents and blood banking materials, was awarded a $4,740 delivery order by the Defense Logistics Agency's Medical Supply Chain division on October 30, 2025, for ALBACLONE Anti-B monoclonal antibodies. The contract, utilizing firm fixed pricing with no set-aside designation, is scheduled for completion by November 4, 2025, and will be performed in Chicago, Illinois. This delivery order represents a...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $1,670 firm fixed-price delivery order to Alba Bioscience, Inc. on February 2, 2026, for an Albacyte Antibody Screen in 2-cell configuration. The award carries an ultimate completion date of April 7, 2026, and will be performed at the company's Chicago, Illinois facility. This contract was awarded without set-aside designation, reflecting Alba Bioscience's competitive capabilities in specialized immunohematology products...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $1,115.79 to Alba Bioscience, Inc. for the ALBACYTE Antibody ID Panel (16-Cell) on October 30, 2025, with an ultimate completion date of January 7, 2026. The contract is a firm fixed-price delivery order with no set-aside designation, reflecting Alba Bioscience's competitive standing as a specialized supplier of immunohematology reagents and blood banking diagnostic materials. Alba Bioscience, a...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $2,400 firm fixed-price delivery order to Alba Bioscience, Inc. on January 23, 2026, for ALBACYTE IgG sensitized cells II, with completion scheduled for March 30, 2026. Alba Bioscience, a Chicago-based subsidiary of Quotient Biodiagnostics, Inc., specializes in providing in vitro diagnostic products and blood banking materials to federal healthcare systems. The contract was awarded without set-aside designation, reflecting...
- The Defense Logistics Agency, operating under the Defense or Civilian designation, awarded a delivery order contract (4568409675) to Alba Bioscience, Inc. on June 2, 2025, for the supply of ALBACLONE Anti-K antibodies. The contract represents a firm fixed price delivery order with a ceiling value of $15,944.00 and an ultimate completion date of June 5, 2025. The award was made on a non-set-aside basis, reflecting Alba Bioscience's competitive standing as an established supplier of specialized...
- Alba Bioscience, Inc., a Chicago-based specialist in immunohematology reagents and blood banking diagnostic products, was awarded a $1,640 delivery order (Contract No. 4570611216) by the Defense Logistics Agency's Medical Supply Chain division on January 23, 2026. The order, designated for ALBACLONE Anti-K monoclonal antibodies, carries a firm fixed price and an ultimate completion date of January 28, 2026, with performance at the company's facility in Chicago, Illinois. This delivery order...
- Alba Bioscience, Inc. received a $2,030 firm fixed-price delivery order from the Department of Defense's Medical Supply Chain on June 5, 2025, for the ALBACYTE Antibody ID Panel (16-Cell). The contract, which carries an ultimate completion date of August 11, 2025, was awarded without a set-aside designation, reflecting Alba Bioscience's competitive standing as a supplier of specialized in vitro diagnostic products. Performance will take place in Chicago, Illinois, where the vendor maintains...
- The Defense Health Agency awarded a $45,227.88 firm fixed-price purchase order to Alba Bioscience, Inc. on October 1, 2023, for Z451U ALBACLYE screening cells antibody products. This award represents the second-year funding option covering Contract Line Items 2001-2020 and is scheduled for completion by September 30, 2028. The contract will be performed at Alba Bioscience's facility in Fort Johnson, South Carolina. No set-aside designation was applied to this award, reflecting the specialized...